EGFR and colonic neoplasm: The combined outcomes of in vitro cell assays and molecular gene and protein analyses support the bioactivity of the extract’s compounds in the suppression of colon cancer cell migration and invasion and the inhibition of colony formation through the upstream (EGFR) and downstream (EMT) pathways in colon cancer.